News Feed
The Download: GLP-1s and eating disorders, self-aware cities, and forever chemicals
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Eating disorders are on the rise. GLP-1s could make things…
Sex Chromosome Aneuploidies and the Brain: from Neurodevelopmental Risk to Fundamental Biology
Sex chromosome aneuploidies (SCAs) are collectively common (∼1/400 individuals) conditions that involve loss or gain of one or more X- or Y- chromosomes. A recent surge in SCA research has highlighted their underappreciated penetrance…
Trends in Autism Spectrum Disorder Cumulative Incidence and Incidence Density: A Systematic Review
Claims of an “autism epidemic” imply a true increase in ASD occurrence and changing underlying risk yet largely rely on rising prevalence estimates rather than incidence. Both measures are influenced by diagnostic practices, service…
News
3117 results
Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03180-7Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Improving multimodal wearable sensing for healthcare with artificial intelligence
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03134-zThis Comment explores artificial intelligence-driven strategies to accelerate the clinical translation of multimodal wearable sensors. We outline key data-science challenges and highlight disease contexts in which these systems could support therapeutic interventions.
Programming biology: next-gen AI firms raise billions to design better medicines
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03170-9Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
A framework for building a synthetic cell from the SynCell Asia Initiative
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03153-wBuilding a living cell from scratch requires overcoming a bottleneck that has remained unresolved despite decades of progress: orchestrating the spatiotemporal integration of core functional modules. To tackle this barrier, the SynCell Asia…
Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03140-1A wearable ultrasound device is optimized for continuous monitoring of pregnancies.
Enabling secure discovery in trusted research environments with improved tooling
Nature Medicine, Published online: 26 May 2026; doi:10.1038/s41591-026-04401-xBiobanks are introducing trusted research environments to enable secure data access, yet they can increase costs and complexity for biomedical researchers who use them. We discuss challenges and solutions and introduce the Python…
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Nature Medicine, Published online: 26 May 2026; doi:10.1038/s41591-026-04376-9In a multicenter phase 2 trial, the fibroblast growth factor receptor inhibitor rogaratinib showed encouraging clinical efficacy in patients with succinate dehydrogenase-deficient gastrointestinal stromal tumors, suggesting a potential new treatment option for this…
Microglial mitochondria transfer to astrocytes via GPNMB-enriched extracellular vesicles alleviates cognitive deficits in tauopathy mice
Nature Neuroscience, Published online: 26 May 2026; doi:10.1038/s41593-026-02317-wIn PS19 mice, microglia-derived glycoprotein nonmetastatic melanoma protein B promotes mitochondrial extracellular vesicle secretion, enabling mitochondrial transfer to astrocytes. This improves astrocytic function and reduces Alzheimer’s disease (AD) symptoms, while GPNMB deficiency impairs…
STAT+: Eli Lilly to buy three small vaccine developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.
It’s time to address the looming crisis in entry-level work.
Artificial intelligence has not so far produced a clean story of mass unemployment. Aggregate employment in developed countries remains broadly stable, and recent assessments have found limited evidence that AI has shifted the headline numbers. But a troubling change may…
A reality check on the AI jobs hysteria
Haven’t you heard? White-collar jobs are going away, decimated by AI. Waves of layoffs in the tech sector (most recently at Coinbase and Meta and Cisco) are said to presage what will soon come for all of us knowledge workers.…
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.
Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write eight former CDC directors.
Opinion: The Ebola outbreak will lead to devastating violence against women and girls
“Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write researchers Lindsay Stark and Ilana Seff.
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025. They…
Virtual Forest-Based Mindfulness for Perinatal Mental Health
Conditions: Perinatal Anxiety; Perinatal Depression; Maternal Mental Health Interventions: Behavioral: Virtual Reality Forest Mindfulness Intervention; Behavioral: Conventional Mindfulness Intervention Sponsors: National Taiwan University Hospital Not yet recruiting
Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
Conditions: Prader-Willi Syndrome Interventions: Behavioral: Regulating Together group therapy Sponsors: Children's Mercy Hospital Kansas City; Foundation for Prader-Willi Research Recruiting
Psychological Stress and Support Needs of Volunteer First Responders After Smartphone-based Cardiac Arrest Alerts
Conditions: Mental Health; Stress Disorder, Post Traumatic Interventions: Behavioral: Structured Debriefing Sponsors: University Hospital, Aachen; Alexianer Center for Mental Health Care, Aachen; Aachen Institute for Rescue Management and Public Safety (ARS), RWTH Aachen University Not yet recruiting
Testing a Smartphone-Based Intervention Targeting Anxiety Sensitivity Among Women Presenting for Emergency Care After Sexual Assault: Pilot Randomized Controlled Trial
Background: Anxiety sensitivity (AS), defined as the fear of anxious arousal, is a promising therapeutic target for reducing posttraumatic stress disorder (PTSD) symptom development after trauma exposure. Initial research suggests that smartphone-based AS interventions may be acceptable to sexual assault…
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.
News Feed
The Download: GLP-1s and eating disorders, self-aware cities, and forever chemicals
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Eating disorders are on the rise. GLP-1s could make things…
Sex Chromosome Aneuploidies and the Brain: from Neurodevelopmental Risk to Fundamental Biology
Sex chromosome aneuploidies (SCAs) are collectively common (∼1/400 individuals) conditions that involve loss or gain of one or more X- or Y- chromosomes. A recent surge in SCA research has highlighted their underappreciated penetrance…
Trends in Autism Spectrum Disorder Cumulative Incidence and Incidence Density: A Systematic Review
Claims of an “autism epidemic” imply a true increase in ASD occurrence and changing underlying risk yet largely rely on rising prevalence estimates rather than incidence. Both measures are influenced by diagnostic practices, service…
News
3117 results
Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03180-7Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Improving multimodal wearable sensing for healthcare with artificial intelligence
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03134-zThis Comment explores artificial intelligence-driven strategies to accelerate the clinical translation of multimodal wearable sensors. We outline key data-science challenges and highlight disease contexts in which these systems could support therapeutic interventions.
Programming biology: next-gen AI firms raise billions to design better medicines
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03170-9Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
A framework for building a synthetic cell from the SynCell Asia Initiative
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03153-wBuilding a living cell from scratch requires overcoming a bottleneck that has remained unresolved despite decades of progress: orchestrating the spatiotemporal integration of core functional modules. To tackle this barrier, the SynCell Asia…
Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03140-1A wearable ultrasound device is optimized for continuous monitoring of pregnancies.
Enabling secure discovery in trusted research environments with improved tooling
Nature Medicine, Published online: 26 May 2026; doi:10.1038/s41591-026-04401-xBiobanks are introducing trusted research environments to enable secure data access, yet they can increase costs and complexity for biomedical researchers who use them. We discuss challenges and solutions and introduce the Python…
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Nature Medicine, Published online: 26 May 2026; doi:10.1038/s41591-026-04376-9In a multicenter phase 2 trial, the fibroblast growth factor receptor inhibitor rogaratinib showed encouraging clinical efficacy in patients with succinate dehydrogenase-deficient gastrointestinal stromal tumors, suggesting a potential new treatment option for this…
Microglial mitochondria transfer to astrocytes via GPNMB-enriched extracellular vesicles alleviates cognitive deficits in tauopathy mice
Nature Neuroscience, Published online: 26 May 2026; doi:10.1038/s41593-026-02317-wIn PS19 mice, microglia-derived glycoprotein nonmetastatic melanoma protein B promotes mitochondrial extracellular vesicle secretion, enabling mitochondrial transfer to astrocytes. This improves astrocytic function and reduces Alzheimer’s disease (AD) symptoms, while GPNMB deficiency impairs…
STAT+: Eli Lilly to buy three small vaccine developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.
It’s time to address the looming crisis in entry-level work.
Artificial intelligence has not so far produced a clean story of mass unemployment. Aggregate employment in developed countries remains broadly stable, and recent assessments have found limited evidence that AI has shifted the headline numbers. But a troubling change may…
A reality check on the AI jobs hysteria
Haven’t you heard? White-collar jobs are going away, decimated by AI. Waves of layoffs in the tech sector (most recently at Coinbase and Meta and Cisco) are said to presage what will soon come for all of us knowledge workers.…
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.
Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write eight former CDC directors.
Opinion: The Ebola outbreak will lead to devastating violence against women and girls
“Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write researchers Lindsay Stark and Ilana Seff.
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025. They…
Virtual Forest-Based Mindfulness for Perinatal Mental Health
Conditions: Perinatal Anxiety; Perinatal Depression; Maternal Mental Health Interventions: Behavioral: Virtual Reality Forest Mindfulness Intervention; Behavioral: Conventional Mindfulness Intervention Sponsors: National Taiwan University Hospital Not yet recruiting
Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
Conditions: Prader-Willi Syndrome Interventions: Behavioral: Regulating Together group therapy Sponsors: Children's Mercy Hospital Kansas City; Foundation for Prader-Willi Research Recruiting
Psychological Stress and Support Needs of Volunteer First Responders After Smartphone-based Cardiac Arrest Alerts
Conditions: Mental Health; Stress Disorder, Post Traumatic Interventions: Behavioral: Structured Debriefing Sponsors: University Hospital, Aachen; Alexianer Center for Mental Health Care, Aachen; Aachen Institute for Rescue Management and Public Safety (ARS), RWTH Aachen University Not yet recruiting
Testing a Smartphone-Based Intervention Targeting Anxiety Sensitivity Among Women Presenting for Emergency Care After Sexual Assault: Pilot Randomized Controlled Trial
Background: Anxiety sensitivity (AS), defined as the fear of anxious arousal, is a promising therapeutic target for reducing posttraumatic stress disorder (PTSD) symptom development after trauma exposure. Initial research suggests that smartphone-based AS interventions may be acceptable to sexual assault…
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.